Blood methylomics in response to arsenic exposure in a low-exposed US population

Journal of Exposure Science and Environmental Epidemiology

Volumn 24, Issue 2, 2014, Pages 145-149

  Liu, Xin ^a   Zheng, Yinan ^b   Zhang, Wei ^c   Zhang, Xiao ^a   Lioyd Jones, Donald M ^a   Baccarelli, Andrea A ^d   Ning, Hongyan ^a   Fornage, Myriam ^e   He, Ka ^f   Liu, Kiang ^a   Hou, Lifang ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

arsenic exposure; methylomic profiling; prospective association

Indexed keywords

ARSENIC;

ARTICLE; CASE CONTROL STUDY; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; HUMAN; MULTICENTER STUDY; PROSPECTIVE STUDY; UNITED STATES;

ARSENIC; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; HUMANS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84896735929     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2013.89     Document Type: Article

References (44)

1. Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect 2013; 121: 295-302.
2. International Agency for Research on Cancer. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl 1987; 7: 1-440.
3. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 2011; 119: 11-19.
4. Smith AH, Steinmaus CM. Health effects of arsenic and chromium in drinking water: recent human findings. Annu Rev Public Health 2009; 30: 107-122.
5. Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X et al. Arsenic in drinking water and lung cancer: a systematic review. Environ Res 2008; 108: 48-55.
6. Baastrup R, Sorensen M, Balstrom T, Frederiksen K, Larsen CL, Tjonneland A et al. Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect 2008; 116: 231-237.
7. Islam R, Khan I, Hassan SN, McEvoy M, D'Este C, Attia J et al. Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ Health 2012; 11: 38.
8. Maull EA, Ahsan H, Edwards J, Longnecker MP, Navas-Acien A, Pi J et al. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect 2012; 120: 1658-1670.
9. Rhee SY, Hwang YC, Woo JT, Chin SO, Chon S, Kim YS. Arsenic exposure and prevalence of diabetes mellitus in Korean adults. J Korean Med Sci 2013; 28: 861-868.
10. Zierold KM, Knobeloch L, Anderson H. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 2004; 94: 1936-1937.
11. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 2007; 6: 4.
12. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 1999; 107: 359-365.
13. Rahman MM, Chowdhury UK, Mukherjee SC, Mondal BK, Paul K, Lodh D et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India-A review and commentary. J Toxicol Clin Toxicol 2001; 39: 683-700.
14. Gong G, O'Bryant SE. The arsenic exposure hypothesis for Alzheimer disease. Alzheimer Dis Assoc Disord 2010; 24: 311-316.
15. Hou LF, Zhang X, Wang D, Baccarelli A. Environmental chemical exposures and human epigenetics. Int J Epidemiol 2012; 41: 79-105.
16. Hou LF, Wang D, Baccarelli A. Environmental chemicals and microRNAs. Mutat Res 2011; 714: 105-112.
17. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 2007; 352: 188-192.
18. Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic-induced DNA. hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 2004; 25: 413-417.
19. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 2004; 25: 1779-1786.
20. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997; 386: 263-277.
21. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr 2007; 86: 1179-1186.
22. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. Arsenic exposure induces genomic hypermethylation. Environ Toxicol 2010; 25: 315-318.
23. Chanda S, Dasgupta UB, Guhamazumder D, Gupta M, Chaudhuri U, Lahiri S et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 2006; 89: 431-437.
24. Smeester L, Rager JE, Bailey KA, Guan X, Smith N, Garcia-Vargas G et al. Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol 2011; 24: 165-167.
25. Bailey KA, Wu MC, Ward WO, Smeester L, Rager JE, Garcia-Vargas G et al. Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol 2013; 27: 106-115.
26. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect 2013; 121: 971-977.
27. Zhang AH, Bin HH, Pan XL, Xi XG. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J Toxicol Environ Health A 2007; 70: 970-975.
28. Gruber JF, Karagas MR, Gilbert-Diamond D, Bagley PJ, Zens MS, Sayarath V et al. Associations between toenail arsenic concentration and dietary factors in a New Hampshire population. Nutr J 2012; 11: 45.
29. Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J et al. Hair and toenail arsenic concentrations of residents living in areas with high environmental arsenic concentrations. Environ Health Perspect 2003; 111: 187-193.
30. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 2000; 152: 84-90.
31. Seow WJ, Pan WC, Kile ML, Baccarelli AA, Quamruzzaman Q, Rahman M et al. Arsenic reduction in drinking water and improvement in skin lesions: a follow-up study in Bangladesh. Environ Health Perspect 2012; 120: 1733-1738.
32. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, Jr et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-1116.
33. Nichols TA, Morris JS, Mason MM, Spate VL, Baskett CK, Cheng TP et al. The study of human nails as an intake monitor for arsenic using neutron activation analysis. J Radioanal Nucl Chem 1998; 236: 51-56.
34. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L et al. Comparison of Betavalue and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 2010; 11: 587.
35. Moen EL, Zhang X, Mu W, Delaney SM, Wing C, McQuade J et al. Genome-wide variation of Cytosine modifications between European and african populations and the implications for complex traits. Genetics 2013; 194: 987-996.
36. Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 2013; 14: 293.
37. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 8: 118-127.
38. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012; 13: 86.
39. Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE et al. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 2009; 4: e6767.
40. El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007; 122: 505-514.
41. Liu J, Morgan M, Hutchison K, Calhoun VD. A study of the influence of sex on genome wide methylation. PLoS One 2010; 5: e10028.
42. Fratelli M, Goodwin LO, Orom UA, Lombardi S, Tonelli R, Mengozzi M et al. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA 2005; 102: 13998-14003.
43. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 1997; 37: 397-419.
44. Anetor JI, Wanibuchi H, Fukushima S. Arsenic exposure and its health effects and risk of cancer in developing countries: micronutrients as host defence. Asian Pac J Cancer Prev 2007; 8: 13-23.